Pacira BioSciences Inc (PCRX)
26.35
+0.85
(+3.33%)
USD |
NASDAQ |
Apr 26, 16:00
26.35
0.00 (0.00%)
After-Hours: 20:00
Pacira BioSciences Accounts Payable (Quarterly): 15.70M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 15.70M |
September 30, 2023 | 16.51M |
June 30, 2023 | 24.21M |
March 31, 2023 | 17.26M |
December 31, 2022 | 15.22M |
September 30, 2022 | 12.93M |
June 30, 2022 | 13.98M |
March 31, 2022 | 14.84M |
December 31, 2021 | 10.54M |
September 30, 2021 | 7.895M |
June 30, 2021 | 12.18M |
March 31, 2021 | 9.11M |
December 31, 2020 | 10.43M |
September 30, 2020 | 13.01M |
June 30, 2020 | 9.16M |
March 31, 2020 | 15.85M |
December 31, 2019 | 12.80M |
September 30, 2019 | 16.06M |
June 30, 2019 | 13.35M |
March 31, 2019 | 13.37M |
December 31, 2018 | 14.37M |
September 30, 2018 | 13.80M |
June 30, 2018 | 14.26M |
March 31, 2018 | 14.91M |
December 31, 2017 | 14.66M |
Date | Value |
---|---|
September 30, 2017 | 12.28M |
June 30, 2017 | 10.39M |
March 31, 2017 | 9.373M |
December 31, 2016 | 7.511M |
September 30, 2016 | 7.287M |
June 30, 2016 | 4.614M |
March 31, 2016 | 10.48M |
December 31, 2015 | 8.739M |
September 30, 2015 | 8.471M |
June 30, 2015 | 13.30M |
March 31, 2015 | 5.565M |
December 31, 2014 | 6.758M |
September 30, 2014 | 7.747M |
June 30, 2014 | 3.145M |
March 31, 2014 | 2.605M |
December 31, 2013 | 3.069M |
September 30, 2013 | 1.559M |
June 30, 2013 | 1.712M |
March 31, 2013 | 1.001M |
December 31, 2012 | 2.569M |
September 30, 2012 | 4.789M |
June 30, 2012 | 0.44M |
March 31, 2012 | 2.302M |
December 31, 2011 | 3.44M |
September 30, 2011 | 4.313M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
7.895M
Minimum
Sep 2021
24.21M
Maximum
Jun 2023
13.74M
Average
13.35M
Median
Jun 2019
Accounts Payable (Quarterly) Benchmarks
Dynavax Technologies Corp | 5.245M |
Arbutus Biopharma Corp | 3.223M |
Chimerix Inc | 2.851M |
Karyopharm Therapeutics Inc | 3.123M |
FibroGen Inc | 17.96M |